524 related articles for article (PubMed ID: 1855205)
21. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
Labrie F; Labrie C; Bélanger A; Simard J; Gauthier S; Luu-The V; Mérand Y; Giguere V; Candas B; Luo S; Martel C; Singh SM; Fournier M; Coquet A; Richard V; Charbonneau R; Charpenet G; Tremblay A; Tremblay G; Cusan L; Veilleux R
J Steroid Biochem Mol Biol; 1999; 69(1-6):51-84. PubMed ID: 10418981
[TBL] [Abstract][Full Text] [Related]
22. Acetaminophen-induced proliferation of breast cancer cells involves estrogen receptors.
Harnagea-Theophilus E; Gadd SL; Knight-Trent AH; DeGeorge GL; Miller MR
Toxicol Appl Pharmacol; 1999 Mar; 155(3):273-9. PubMed ID: 10079213
[TBL] [Abstract][Full Text] [Related]
23. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
24. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
Lykkesfeldt AE; Larsen SS; Briand P
Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
[TBL] [Abstract][Full Text] [Related]
25. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
26. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
Dipippo VA; Powers CA
J Pharmacol Exp Ther; 1997 Apr; 281(1):142-8. PubMed ID: 9103491
[TBL] [Abstract][Full Text] [Related]
28. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
[TBL] [Abstract][Full Text] [Related]
29. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
30. RU 58,668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice.
Van de Velde P; Nique F; Bouchoux F; Brémaud J; Hameau MC; Lucas D; Moratille C; Viet S; Philibert D; Teutsch G
J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):187-96. PubMed ID: 8142294
[TBL] [Abstract][Full Text] [Related]
31. The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription.
Nawaz Z; Stancel GM; Hyder SM
Cancer Res; 1999 Jan; 59(2):372-6. PubMed ID: 9927049
[TBL] [Abstract][Full Text] [Related]
32. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
Poulin R; Merand Y; Poirier D; Levesque C; Dufour JM; Labrie F
Breast Cancer Res Treat; 1989 Oct; 14(1):65-76. PubMed ID: 2605344
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.
Huynh HT; Pollak M
Cancer Res; 1993 Dec; 53(23):5585-8. PubMed ID: 8242606
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
35. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
[TBL] [Abstract][Full Text] [Related]
36. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
37. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Müller V; Jensen EV; Knabbe C
Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents.
Magarian RA; Avor KS; Overacre LB; Kunchandy J; Paxton TR
Anticancer Drug Des; 1995 Jun; 10(4):311-31. PubMed ID: 7786397
[TBL] [Abstract][Full Text] [Related]
39. Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Cancer Chemother Pharmacol; 1996; 38(3):238-44. PubMed ID: 8646798
[TBL] [Abstract][Full Text] [Related]
40. Antiuterotrophic effects of a pure antioestrogen, ICI 182,780: magnetic resonance imaging of the uterus in ovariectomized monkeys.
Dukes M; Miller D; Wakeling AE; Waterton JC
J Endocrinol; 1992 Nov; 135(2):239-47. PubMed ID: 1474330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
